Add Company
Join Now

AgonOx Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AgonOx's estimated annual revenue is currently $930k per year.(i)
  • AgonOx's estimated revenue per employee is $155,000

Employee Data

  • AgonOx has 6 Employees.(i)
  • AgonOx grew their employee count by 0% last year.

AgonOx's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
Head Corporate DevelopmentReveal Email/Phone
3
Director Research & DevelopmentReveal Email/Phone
4
Research Associate II / Lab ManagerReveal Email/Phone
5
President and CSOReveal Email/Phone
6
Research ScientistReveal Email/Phone
7
Research Associate IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-54%N/AN/A
#2
$18.8M12111%N/AN/A
#3
$6.8M447%N/AN/A
#4
$0.8M50%N/AN/A
#5
$35.8M18538%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$2.6M170%N/AN/A
#8
$0.8M50%N/AN/A
#9
$8.1M524%N/AN/A
#10
$0.8M50%N/AN/A
Add Company

What Is AgonOx?

AgonOx, Inc.is a spin-off company from the Providence Cancer Center located in Portland, Oregon. We are developing immune system activators for use in cancer therapy. Research in the field of T-cell modulation conducted worldwide with OX40 and other agents has demonstrated that the use of T-cell modulating therapies in combination with specific anti-tumor therapies have the potential for yielding therapeutic benefits for patients with cancer. AgonOx is focused on the development of immune system modulators in combination with other promising agents in the immune oncology space.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M6-25%N/A
#2
$0.4M6N/AN/A
#3
$0.4M6N/AN/A
#4
$0.4M6N/AN/A
#5
$0.4M6N/AN/A